Professional Documents
Culture Documents
Avolta VC Exit Multiples France 2023
Avolta VC Exit Multiples France 2023
Avolta VC Exit Multiples France 2023
The BVP Nasdaq Emerging Cloud Index, a barometer of public tech valuations in 1,600
120
the US, reveals an impressive +17% surge from January through September. 1,400
However, a somewhat concerning -10% net change in Q3-23 warrants attention. 100
1,200
September witnessed significant IPOs on the NYSE, notably the highly 1,000 80
anticipated $55bn offering of the British Softbank-owned chip-designer Arm, 800 60
marking the largest IPO on the exchange in two years, alongside marketing
600
software giant Klaviyo at $10bn. 40
400
These triumphant IPOs are poised to pave the way for more to come, reigniting 200
20
ambitious aspirations among private market investors.
- -
Turning our gaze to France's private market, signs of recovery are emerging. The
22
23
23
2
3
23
23
23
23
3
-2
-2
-2
l-2
-2
b-
c-
n-
g-
n-
p-
r-
colossal €2.2bn secured by electric battery manufacturer Verkor in September,
ct
ar
ay
ov
Ju
Ap
Au
Ja
Ju
Fe
De
Se
M
O
M
N
comprising €850m in equity, €600m in debt, and €650m in subsidies, bodes well
for the sector. €1.6bn total exit value for French Tech in Q3-23, the highest quarter this year
Moreover, the cumulative funds raised by French Tech startups have plateaued Exit value (€m) Deal count (#)
at approximately €2bn for a fourth consecutive quarter. M&A activity in Q3-23 800 80
reached a total deal value of €1.6bn, marking one of the highest quarters in the
past two years. 700 70
600 60
In terms of capital increase multiples, Fintech and Medtech have experienced the
most pronounced impacts, with an approximate 30% decline in their EV multiples 500 50
compared to the previous year, whereas other sectors have seen positive shifts. 400 40
300 30
Regarding exits, the subscription model is receiving more acclaim than ever, with
a +16% EV multiple expansion year over year. 200 20
100 10
- -
22
23
23
2
3
23
3
23
3
23
23
-2
-2
l-2
-2
-2
Arthur Porré, Founding Partner - Oct. 3rd, 2023
c-
n-
b-
g-
n-
p-
r-
ct
ay
ar
ov
Ju
Ap
Au
Ja
Ju
De
Fe
Se
M
O
M
N
Total fundraising amount in Europe (€bn) Total no. of European unicorns (#)
80 200
The UK still leading mega-deals
60 150 2023
50 2022
40 100 2021
30 2020
20 50 2019
2018
10
- 50 100
- -
2018 2019 2020 2021 2022 2023
Actuals UK Germany France
UK France Germany Rest of Europe Annualized fundraising amount
Projections UK Germany France
16 1,400
14.8
14
1,200
13.3
12
1,000
10
800
8 8.7
600
6 6.5 6.5
400
4 4.6
2.9 200
2
- -
2018 2019 2020 2021 2022 2023
- - 5. €100m
Lead by Left Lane Capital
23
Q 0
20
Q 1
Q 1
Q 1
Q 2
Q 2
22
19
19
19
18
18
18
Q 3
Q 0
19
18
Q 0
Q 1
Q 2
Q 3
2
2
2
2
2
2
2
2
2
3-
4-
1-
1-
3-
4-
3-
4-
1-
2-
2-
2-
1-
3-
4-
3-
1-
3-
4-
1-
2-
2-
2-
Q
Q
Q
Q
Q
Q
Q
20
21
21
22
22
22
19
18
18
18
23
20
21
19
18
19
19
21
22
23
20
1-
3-
4-
3-
4-
3-
4-
1-
1-
2-
2-
2-
1-
3-
4-
3-
1-
3-
4-
1-
2-
2-
2-
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
(*) €2,250m total amount raised, out of which €850m of equity, €600m in debt and €650m in subsidies
14,000
1,200
12,000
1,000
10,000
800
8,000
600
6,000
400
4,000
200
2,000
- -
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
5.8
5.4
5.1
*
4.4
3.7 3.7
*
3.0 2.9 *
2.7
*
2.2
2.0 1.9 *
1.8 1.8 1.8 1.8
1.7 1.7 1.7
1.5 1.5
1.3 1.2
1.1 1.1 1.0
0.9 0.9 0.9 0.9 0.8 0.8
0.8
Status reached before 2023 Already unicorn that raised in 2023 Status reached in 2023
Sep.23 – Series C May. 23 – Growth Equity Jan. 22 – Series C Oct. 21 – Series C Jun. 22 – Series A
€1,350m* €250m €185m €172m €160m
Mar. 22 – Series C Sep. 20 – Series C Jun. 22 – Series C+ Jul. 22 – Series C+ Nov. 21 – Series B
€150m €140m €133m €130m €125m
NEW
Mar. 22 – Series D Sep. 23 – Series B Jan. 22 – Series B Jun. 23 – Seed Jan. 23 – Series B
€122m €108m €107m €105m €100m
NEW
May 23 – Series C May 21 – Series B Feb. 22 – Growth Equity Apr. 22 – Series B May. 23 – Series B+
€88m €82m €80m €73m €30m
(*) €2,250m total amount raised, out of which €850m of equity, €600m in debt and €650m in subsidies
100%
1,000
90% *
80%
100
70%
60%
50% 10
40%
30%
1
20%
10%
- 0
Q3-21
Q4-21
Q3-20
Q4-20
Q3-22
Q4-22
Q1-21
Q3-23
Q1-20
Q1-22
Q2-18
Q1-23
Q2-19
Q3-18
Q4-18
Q3-19
Q4-19
Q1-18
Q1-19
Q2-21
Q2-20
Q2-22
Q2-23
23
Q 20
Q 0
Q 21
Q 21
Q 22
Q 2
Q 19
Q 18
Q 23
Q 20
Q 21
Q 22
Q 19
Q 18
Q 19
Q 19
Q 18
Q 8
Q 22
Q 23
Q 20
Q 21
2
1
2
1-
3-
4-
3-
4-
1-
1-
3-
4-
2-
2-
2-
3-
4-
3-
1-
1-
3-
4-
1-
2-
2-
2-
Q
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
-
Q1-18 Q2-18 Q3-18 Q4-18 Q1-19 Q2-19 Q3-19 Q4-19 Q1-20 Q2-20 Q3-20 Q4-20 Q1-21 Q2-21 Q3-21 Q4-21 Q1-22 Q2-22 Q3-22 Q4-22 Q1-23 Q2-23 Q3-23
Note: « Others » category includes Performance, Retail, Service, E-commerce and Audience business models
Energy (- 4%)
Transportation (+ 14%)
Health (- 48%)
Fintech (- 77%)
Semiconductors (+ 119%)
Food (- 49%)
Security (-26 %)
Media (- 24%)
Travel (+ 56%)
Robotics (- 77%)
Education (+ 14%)
Space (- 24%)
Fashion (- 75%)
Hosting (- 50%)
Telecom (- 59%)
1. 1 30 deals*
500 2. 8 9 deals
3. 1 8 deals
400
4. 3 7 deals
300
5. New 4 deals
6. 1 4 deals
200
7. New 3 deals
100
8. New 3 deals
9. New 3 deals
-
22
22
21
21
23
19
20
20
18
23
20
22
21
19
19
18
18
19
18
23
20
22
21
3-
4-
3-
4-
1-
3-
4-
1-
1-
2-
2-
2-
3-
4-
3-
1-
1-
3-
4-
1-
2-
2-
2-
Q
Q
Q
Q
Q
Q
Q
Q
Q
26.6
7.0
1.4 0.3
Round 1 Round 2 Round 3 Round 4 Round 5
Median Age 3 4 5 6 6
Total amount raised by French VCs should neighbor €3bn in 2023 New VC funds raised in Q3-23
Funds raised by French VCs (€bn) Funds raised by French VCs (#)
4 30 €400m
1. Raised in Jul. 2023
3.8
25
3
3.0
€250m
20 2. Raised in Jul. 2023
2.7
2 15
2.0
€75m
10 3. Raised in Sept. 2023
1.3
1.2
1 1.1
€40m
4. Raised in Sept. 2023
- -
2018 2019 2020 2021 2022 2023
Annualized amount raised by French VCs (€bn) Annualized funds raised (#)
50%
12.0 12.0
11.2x Quartile 3
45%
9.9x
10.0 10.0
40%
1
35%
8.0 8.0
30%
Median (YoY%)
25% 6.0 6.0
6.1x (+ 10.0%)
20%
Quartile 1
10% 2.9x
2.0 2.5x 2.0
5%
- - -
French investors At least one
23
20
20
21
21
21
22
22
22
19
19
19
18
18
18
23
20
19
18
20
21
22
23
on ly foreign investor
3-
4-
1-
1-
3-
4-
3-
4-
1-
2-
2-
2-
1-
3-
4-
3-
1-
3-
4-
1-
2-
2-
2-
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Note: This graph depicts the % of deals in which at least one investor of a specific country/region is participating
(1) % of deals with at least one foreign investor
1. Led by Macquarie
€1,350m
4,000
3,000 3. €20m
Led by Eiffel & Crédit Agricole
150
2,500 4. Led by Swen
€19m
2,000
5. Led by VisVires New Protein
€16m
100
1,500
6. Led by Alter Equity
€10m
1,000
50
7. Unknown lead
€10m
500
8. Unknown lead
€5m
- -
2018 2019 2020 2021 2022 2023
9. Led by Frst
€5m
Energy Enterpri se Software Food
Health Other Projected amount raised (€m)
Projected deal count (#) 10. €3m
Led by UI Investissement
Note: Companies addressing one or more of the UN Sustainable Development Goals (SDGs) Avolta acted as sole financial advisor
5.4x (- 32.0%)
4.8x (+ 26.0%)
Commission 1.7x 5.6x
Enterprise Software 3.7x 8.9x
3.8x (+ 7.1%)
2.5x (- 2.2%) MarTech 2.8x 5.8x
3.2x (+ 43.3%)
4.3x (+ 50.0%)
3.4x (+ 38.9%)
HRTech 2.9x 3.6x
Median 0x Median
5x 10x 15x
Quartile 1 (∆ YoY) Quartile 3 Quartile 1 (∆ YoY) Quartile 3
0x 5x 10x
Note: multiples computed on a trailing 24-month dataset , therefore variations correspond to 2023-22 vs. 2022-21
12 450
400
10 10.4
350
8 300
250
200
5.4
5.0
4.8
4 4.5 150
4.0
3.0 100
50
- -
2018 2019 2020 2021 2022 2023
4,500 1. €228m
120 By HID Global
4,000
3,500 100
3,000 80
2,500
60
2,000
2. €226m
1,500 40
By Renesas
1,000
20
500
- -
Q 0
20
Q 1
Q 1
Q 2
22
19
18
Q 3
Q 0
23
Q 1
Q 2
19
18
19
19
18
18
Q 2
Q 3
Q 0
Q 1
2
2
2
2 3. €200m
2
2
2
2
2
2
2
1-
3-
4-
3-
4-
1-
1-
3-
4-
2-
2-
2-
3-
4-
1-
1-
3-
4-
3-
1-
2-
2-
2-
Q
Q
Q
Q
Q
Q
Q
By Hg Capital
Top 1 Top 3 Others
56.4
50.0 50.1
41.7 45.4 41.2
40.0 40.5 40.0
29.0 25.8 28.5
15.0
21.0
15.8 13.0 20.0 18.0 22.5
15.0
20.0 5. €100m
By The Carlyle Group
23
20
20
21
21
22
22
22
19
18
18
18
23
20
21
19
18
19
19
21
22
23
20
1-
3-
4-
3-
4-
3-
4-
1-
1-
2-
2-
2-
1-
3-
4-
3-
1-
3-
4-
1-
2-
2-
2-
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
350
10,000
300
8,000
250
6,000 200
150
4,000
100
2,000
50
- -
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
100%
80%
40%
The Breakaways 50-150 28%
0%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
3. New 2 exits
80%
60%
5. New 2 exits
50%
6. New 2 exits
40%
7. New 2 exits
30%
10%
9. New 1 exit
0%
2018 2019 2020 2021 2022 2023 YTD
10. New 1 exit
Bootstrapped VC backed
5.2x (- 31.7%)
90% Corp. Dev.
Private Equity
70%
3.2x (+ 28.8%)
60% IPO
PE
20%
€52m
10% Corp.
€25m
0%
2018 2019 2020 2021 2022 2023 YTD
Acquisition by a corporate Acquisition by a scale-up Private Equity IPO
Note: multiple computation based on last 5 years
100% 100%
90% 90%
70% 70%
60% 60%
50% 50%
3.1x
40% 40%
30% 30%
20% 20%
2.4x
10% 10%
0% 0%
2018 2019 2020 2021 2022 2023 YTD 2018 2019 2020 2021 2022 2023 YTD
France Europe North America Asia Rest of the World Note: based on transactions with known valuations
200
180 €59.6m
median EV at IPO
160
140
14.0%
120 of companies have shown
a positive return since IPO
100 -2.2%
14%
80
Health
-33.5% Energy
60
9% Hardware
Telecom, Cloud & IoT
40
+231.2% for the B.V.P. Nasdaq Emerging 6% Transportation
Dec-22
Aug-23
Feb-18
Apr-18
Feb-19
Dec-17
Aug-21
Oct-21
Apr-19
Feb-17
Aug-20
Oct-20
Jun-21
Aug-22
Oct-22
Apr-17
Jun-20
Jun-22
Dec-18
Jun-23
Aug-18
Dec-19
Aug-19
Oct-19
Aug-17
Oct-17
Oct-18
Jun-18
Jun-19
Jun-17
Apr-21
Apr-20
Apr-22
Feb-23
Apr-23
Feb-21
Feb-20
Feb-22
5% 2%
5.0x (+ 0.0%)
2.0x (- 10.3%)
1.9x (- 10.1%) MarTech 1.2x 5.2x
3.3x (+ 7.5%)
0x 5x 10x
Mobility 1.6x 5.8x
4.2x (+ 30.0%)
3.4x (+ 22.0%)
HRTech 1.0x 10.3x
Median 0x Median
5x 10x 15x
Quartile 1 (∆ YoY) Quartile 3 Quartile 1 (∆ YoY) Quartile 3
Note: multiples computed on a trailing 24-month dataset , therefore variations correspond to 2023-22 vs. 2022-21
We chose from the beginning in 2012 to be pan-European and data-driven. So, we built Avolta.io, a unique platform to automate processes and scale our ability to
help fast-growing tech companies in Europe.
Our platform concatenates European deals in the tech Industry with information on valuation, revenues and structuration. We source this private data from our
network of providers, business partners and investors, combining it with unique insights from our team of analysts.
2. Scope of research
Business Models Exit types
3. Definitions
Enterprise Value (EV): calculated as Equity Value + Net Debt when legal information is found. Otherwise, estimated EV from several sources: Dealroom.co, Pitchbook,
Pappers, CFNews, Avolta’s private networks and public media.
Avolta Tech Index: composed of Adeunis, Advicenne, Aelis Farma, Affluent Medical, Alveen, Arcure, Balyo, Believe, Boostheat, Broadpeak, Cabasse, Deezer, Don't Nod,
ENENSYS Technologies, Energisme, ERYTECH Pharma, Exclusive Networks, FNP Technologies, Groupe Tera, Haffner Energy, Hopium, Hydrogen-Refueling-Solutions,
Inventiva, Kalray, Keyrus, Kumulus Vape, Largo, Lepermislibre, Lhyfe, MaaT Pharma, Medesis Pharma, Munic, Nacon, namR, Nanobiotix, Obiz, Octopus Biosafety,
Ordissimo, Osmozis, OVH, Predilife, Prodways, S.M.A.I.O, Spartoo, Theranexus, Toosla, UV Germi, Valbiotis, Vente-Unique.com, Vogo, Waga EnergY.
4. Sources
Disclaimer Avolta
The information contained in this document has been produced by Avolta, based on market & legal data and third-party information. While Avolta With 120 deals executed for €2bn in total over the last
has made every effort to ensure the reliability of the data included in this document, Avolta cannot guarantee the accuracy of the information 10 years, Avolta is one of the most active Tech M&A
collected and presented. Therefore, Avolta cannot accept responsibility for any decision made or action taken based upon this document, or the advisors in Europe. Based on this expertise, Avolta’s
information provided herein. team of 20 people has maximised the value of each
This presentation is for the exclusive use of the people to whom it is addressed and is intended for general information purposes only. It is not deal in terms of valuations and overall conditions – this
intended to constitute legal or other professional advice and should not be treated as such. due to its time-tested sectorial methodology and
Appropriate legal advice must be sought before making any decision, taking any action or refraining from taking any action in reliance on the expert negotiating skills
information contained in this presentation. does not assume any responsibility for any person’s reliance upon the information contained herein.